Certified Nurse-Midwife Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Farrah Forney

Advanced Practice Midwife Smithfield, NC Certified Nurse-Midwife

NPI 1417400094 CMS profile 11114165

520 North St, Smithfield, NC 27577

Open in the dashboard

General payments

$2,103

109 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Farrah Forney of Smithfield, NC is reported in the CMS Open Payments database as having received $2,103 across 109 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Advanced Practice Midwife profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $355 17
2024 General $358 16
2023 General $321 16
2022 General $521 29
2021 General $548 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Farrah Forney
  • Advanced Practice Midwife median
  • Middle half of Advanced Practice Midwife
  • National median

In program year 2025, general payments to Farrah Forney were reported at $355. Among 4,127 Advanced Practice Midwife profiles paid that year, the median was $71 and the middle half received between $28 and $161.

Show as a table
Year Farrah Forney Advanced Practice Midwife median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $548 $57 $22–$142 $132
2022 $521 $61 $23–$157 $149
2023 $321 $68 $26–$167 $160
2024 $358 $63 $25–$142 $164
2025 $355 $71 $28–$161 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $467 27 payments
  2. Novo Nordisk Inc $258 14 payments
  3. Mayne Pharma Inc. $252 12 payments
  4. Exeltis, USA Inc. $189 10 payments
  5. Daiichi Sankyo Inc. $146 7 payments
  6. Shield Therapeutics Inc $136 4 payments
  7. Biogen, Inc. $116 5 payments
  8. Mylan Pharmaceuticals Inc. $55 3 payments
  9. Organon LLC $55 4 payments
  10. Evofem Biosciences, Inc. $50 3 payments
  11. Other $379 20 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,103 109 payments
Products named General payments · program years 2021–2025
  1. LO LOESTRIN FE $256 14 payments
  2. ORILISSA $178 11 payments
  3. INJECTAFER $146 7 payments
  4. SLYND $142 7 payments
  5. ACCRUFER $136 4 payments
  6. ORIAHNN $104 7 payments
  7. Wegovy $90 5 payments
  8. LILETTA $76 4 payments
  9. UBRELVY $74 4 payments
  10. Saxenda $63 4 payments
  11. Other $701 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

109 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record